Jean-Luc Stigliani

Jean-Luc Stigliani

Auto-generated profile, based on publicly available information

Jean-Luc Stigliani

Laboratoire de Chimie de Coordination, Université Toulouse III-Paul Sabatier, CNRS (UPR 8241), 205 route de Narbonne, Toulouse F-31077 France

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 July 2018 in European Journal of Medicinal Chemistry
Verified
Journal Article
Open access
JPJulien Pedron
Julien Pedron
CBClotilde Boudot
Clotilde Boudot
SHSébastien Hutter
Sébastien Hutter
SBSandra Bourgeade-Delmas
Sandra Bourgeade-Delmas
JSJean-Luc Stigliani
Jean-Luc Stigliani
PVPierre Verhaeghe
Pierre Verhaeghe
To study the antiparasitic 8-nitroquinolin-2(1H)-one pharmacophore, a series of 31 derivatives was synthesized in 1-5 steps and evaluated in vitro against both Leishmania infantum and Trypanosoma brucei brucei. In parallel, the reduction potential of all molecules was measured by cyclic voltammetry. Structure-activity relationships first indicated that antileishmanial activity depends on an intramolecular hydrogen bond (described by X-ray diffraction) between the lactam function and the nitro group, which is responsible for an important shift of the redox potential (+0.3 V in comparison with 8-nitroquinoline). With the assistance of computational chemistry, a set of derivatives presenting a large range of redox potentials (from -1.1 to -0.45 V) was designed and provided a list of suitable molecules to be synthesized and tested. This approach highlighted that, in this series, only substrates with a redox potential above -0.6 V display activity toward L. infantum. Nevertheless, such relation between redox potentials and in vitro antiparasitic activities was not observed in T. b. brucei. Compound 22 is a new hit compound in the series, displaying both antileishmanial and antitrypanosomal activity along with a low cytotoxicity on the human HepG2 cell line. Compound 22 is selectively bioactivated by the type 1 nitroreductases (NTR1) of L. donovani and T. brucei brucei. Moreover, despite being mutagenic in the Ames test, as most of nitroaromatic derivatives, compound 22 was not genotoxic in the comet assay. Preliminary in vitro pharmacokinetic parameters were finally determined and pointed out a good in vitro microsomal stability (half-life > 40 min) and a 92% binding to human albumin.

29 March 2022 in Pharmaceuticals
Verified
Journal Article
Open access
PDF file
JTJeanne Trognon
Jeanne Trognon
GVGonzalo Vera
Gonzalo Vera
Maya RimaMaya Rima
Maya Rima
JSJean-Luc Stigliani
Jean-Luc Stigliani
LALaurent Amielet
Laurent Amielet
FGFatima El Garah
Fatima El Garah
Biofilm formation is considered a major cause of therapeutic failure because bacteria in biofilms have higher protection against antimicrobials. Thus, biofilm-related infections are extremely challenging to treat and pose major concerns for public health, along with huge economic impacts. Pseudomonas aeruginosa, in particular, is a “critical priority” pathogen, responsible for severe infections, especially in cystic fibrosis patients because of its capacity to form resistant biofilms. Therefore, new therapeutic approaches are needed to complete the pipeline of molecules offering new targets and modes of action. Biofilm formation is mainly controlled by Quorum Sensing (QS), a communication system based on signaling molecules. In the present study, we employed a molecular docking approach (Autodock Vina) to assess two series of chromones-based compounds as possible ligands for PqsR, a LuxR-type receptor. Most compounds showed good predicted affinities for PqsR, higher than the PQS native ligand. Encouraged by these docking results, we synthesized a library of 34 direct and 25 retro chromone carboxamides using two optimized routes from 2-chromone carboxylic acid as starting material for both series. We evaluated the synthesized carboxamides for their ability to inhibit the biofilm formation of P. aeruginosa in vitro. Overall, results showed several chromone 2-carboxamides of the retro series are potent inhibitors of the formation of P. aeruginosa biofilms (16/25 compound with % inhibition ≥ 50% at 50 μM), without cytotoxicity on Vero cells (IC50 > 1.0 mM). The 2,4-dinitro-N-(4-oxo-4H-chromen-2-yl) benzamide (6n) was the most promising antibiofilm compound, with potential for hit to lead optimization.

24 August 2020 in Molecules
Verified
Journal Article
Open access
PDF file
TRThibaud Reyser
Thibaud Reyser
TTTung TO
Tung TO
CEChinedu Ogbonnia Egwu
Chinedu Ogbonnia Egwu
LPLucie Paloque
Lucie Paloque
MNMichel Nguyen
Michel Nguyen
GAGerard Audran
Gerard Audran
Malaria and schistosomiasis are major infectious causes of morbidity and mortality in the tropical and sub-tropical areas. Due to the widespread drug resistance of the parasites, the availability of new efficient and affordable drugs for these endemic pathologies is now a critical public health issue. In this study, we report the design, the synthesis and the preliminary biological evaluation of a series of alkoxyamine derivatives as potential drugs against Plasmodium and Schistosoma parasites. The compounds (RS/SR)-2F, (RR/SS)-2F, and 8F, having IC50 values in nanomolar range against drug-resistant P. falciparum strains, but also five other alkoxyamines, inducing the death of all adult worms of S. mansoni in only 1 h, can be considered as interesting chemical starting points of the series for improvement of the activity, and further structure activity, relationship studies. Moreover, investigation of the mode of action and the rate constants kd for C-ON bond homolysis of new alkoxyamines is reported, showing a possible alkyl radical mediated biological activity. A theoretical chemistry study allowed us to design new structures of alkoxyamines in order to improve the selectivity index of these drugs.

1 October 2021 in Journal of Inorganic Biochemistry
Verified
Journal Article
Closed access
TRTiffany Rundstadler
Tiffany Rundstadler
EMEmmanuelle Mothes
Emmanuelle Mothes
SASamir Amrane
Samir Amrane
JSJean-Luc Stigliani
Jean-Luc Stigliani
PVPierre Verhaeghe
Pierre Verhaeghe
GPGenevieve Pratviel
Genevieve Pratviel

1 March 2021 in Fitoterapia
Verified
Journal Article
Closed access
ALAurélie Lagarde
Aurélie Lagarde
LMLengo Mambu
Lengo Mambu
PMPhuong-Y. Mai
Phuong-Y. Mai
YCYves Champavier
Yves Champavier
JSJean-Luc Stigliani
Jean-Luc Stigliani
MMMarion Millot
Marion Millot

14 November 2018 in Biomolecules
Verified
Journal Article
Open access
PDF file
QZQishun Zhou
Qishun Zhou
BNBao Tram Vu Ngoc
Bao Tram Vu Ngoc
GLGrazyna Leszczynska
Grazyna Leszczynska
JSJean-Luc Stigliani
Jean-Luc Stigliani
GPGenevieve Pratviel
Genevieve Pratviel
Oxidative RNA damage is linked to cell dysfunction and diseases. The present work focuses on the in vitro oxidation of 5-methylaminomethyl uridine (mnm5U), which belongs to the numerous post-transcriptional modifications that are found in tRNA. The reaction of oxone with mnm5U in water at pH 7.5 leads to two aldonitrone derivatives. They form by two oxidation steps and one dehydration step. Therefore, the potential oxidation products of mnm5U in vivo may not be only aldonitrones, but also hydroxylamine and imine derivatives (which may be chemically more reactive). Irradiation of aldonitrone leads to unstable oxaziridine derivatives that are susceptible to isomerization to amide or to hydrolysis to aldehyde derivative.